It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2001.
2001 | Chennai, Tamil Nadu, India | AmalgamatedAindro Pharmaceuticals Private Limited, a amalgamated private limited company, was established on 04 July 2001 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24231TN2001PTC047374. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹16.55 Cr and a paid-up capital of ₹2.93 Cr.
It upholds a compliant status. Its leadership includes Sudhakar Natarajan (Director), Bhuvana (Director). Past directors included Jaganathan Jayaseelan, Nagarajan Pramodh, Thulasi Venkataramanan Brinda. It holds no open charges and ₹37.15 Cr settled loans. Its latest AGM occurred on 28 May 2019, with the balance sheet filed on 31 March 2019. It is based at Plot No.6, Park View Apartments, Nagendra Nagar, Velachery,, Chennai, Tamil Nadu, 600042.
U24231TN2001PTC047374
047374
04 July 2001
₹16.55 Cr
₹2.93 Cr
Roc Chennai
Unlisted
Amalgamated
Explore comprehensive insights into Aindro Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sudhakar Natarajan | Director | 04 Jul 2001 | Current |
| Bhuvana | Director | 02 Jan 2003 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Nov 2009 | Past |
| Pramod Abcsdd | Director | 11 Feb 2019 | Past |
| Pramod Abcsdd | Director | 11 Feb 2019 | Past |
| Pramod Abcsdd | Director | 02 Nov 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aindro Pharmaceuticals Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 791.39% increase. The company also saw a substantial improvement in profitability, with a 305% increase in profit. The company's net worth Soared by an impressive increase of 18.96%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Aindro Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹371,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 May 2007 | State Bank Of India | ₹27.25 Cr | Satisfied |
| 31 Jul 2004 | Union Bank Of India | ₹9.90 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Aindro Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aindro Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aindro Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Aindro Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 May 2019 as per latest MCA records. was recorded as a recent event.
The activity Aindro Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Chennai. was completed.
The activity A charge registered on 05 May 2007 via Charge ID 10110774 with State Bank Of India was fully satisfied on 17 Oct 2012. was completed.
A charge with State Bank Of India of Rs. 27.25 Cr registered on 05 May 2007 with Charge ID 10110774 was modified on 19 Oct 2011. was recorded as a recent event.
A charge registered on 31 Jul 2004 via Charge ID 90290465 with Union Bank Of India was fully satisfied on 17 Apr 2009. was recorded as a recent event.
The activity A charge with State Bank Of India amounted to Rs. 27.25 Cr with Charge ID 10110774 was registered on 05 May 2007. was completed.
The CIN of Aindro Pharmaceuticals Private Limited is U24231TN2001PTC047374.
Aindro Pharmaceuticals Private Limited is headquartered at Plot No.6, Park View Apartments, Nagendra Nagar, Velachery,, Chennai, Tamil Nadu, 600042.
Aindro Pharmaceuticals Private Limited was incorporated on 04 July 2001.
The current directors of Aindro Pharmaceuticals Private Limited are
The primary industry of Aindro Pharmaceuticals Private Limited is Trade.
Aindro Pharmaceuticals Private Limited is unlisted.
The authorized capital of Aindro Pharmaceuticals Private Limited is ₹16.55 Cr, and the paid-up capital is ₹2.93 Cr.
The compliance status of Aindro Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX